Randomized, open-label, comparative study to evaluate early viral load reductions and exploratory viral kinetics following administration of entecavir or adefovir in nucleoside-naive adults with chronic hepatitis B infection.

Trial Profile

Randomized, open-label, comparative study to evaluate early viral load reductions and exploratory viral kinetics following administration of entecavir or adefovir in nucleoside-naive adults with chronic hepatitis B infection.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2010

At a glance

  • Drugs Entecavir (Primary) ; Adefovir dipivoxil
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Acronyms EARLY
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 23 Apr 2008 Status changed from in progress to completed; results at 96 weeks reported at EASL 2008.
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top